{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:52:01Z","timestamp":1776145921458,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Hyperkalaemia is a common condition in patients with comorbidities such as chronic kidney disease (CKD) or congestive heart failure (HF). Moreover, severe hyperkalaemia is a potentially life-threatening condition that is associated with a higher risk of adverse clinical events such as ventricular arrhythmias and sudden cardiac death. Currently, data regarding the prognostic implications of chronic hyperkalaemia are available; however, information about the long-term clinical consequences after an episode of severe hyperkalaemia remains scarce. The objective of this study was to evaluate the association between the trajectory of potassium measurements in patients with acute hyperkalaemia and long-term all-cause mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a retrospective observational study that included patients with acute severe hyperkalaemia [potassium (K)\u2009&amp;gt;6\u2009mEq\/L] without haemolysis in the emergency room of Dr Peset University Hospital in Valencia, Spain searching the lab database from January 2016 to March 2017. The multivariable-adjusted association of serum potassium with mortality was assessed by using comprehensive state-of-the-art regression methods that can accommodate time-dependent exposure modelling.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found 172 episodes of acute hyperkalaemia in 160 patients in the emergency room. The mean \u00b1 standard deviation age of the sample was 77\u2009\u00b1\u200912\u2009years and 60.5% were males. The most frequent comorbidities were CKD (71.2%), HF (35%) and diabetes mellitus (56.9%). Only 11.9% of the patients were on chronic dialysis. A quarter of the patients did not have previous CKD, making hyperkalaemia an unpredictable life-threatening complication. During the acute episode, mean potassium and estimated glomerular filtration rate (eGFR) were 6.6\u2009\u00b1\u20090.6 (range 6.1\u20139.2) mEq\/L and 23\u2009\u00b1\u200916 (range 2\u201384) mL\/min\/1.73 m2, respectively. After a median (interquartile range) follow-up of 17.3 (2.2\u201323.7) months, 68 patients died (42.5%). Recurrences of hyperkalaemia (K\u2009&amp;gt;5.5\u2009mEq\/L) were detected in 39.5% of the patients who were monitored during follow-up. We found that previous potassium levels during an acute severe hyperkalaemia episode were not predictors of mortality. Conversely, the post-discharge longitudinal trajectories of potassium were able to predict all-cause mortality (overall P\u2009=\u20090.0015). The effect of transitioning from hyperkalaemia to normokalaemia (K &amp;gt;5.5 mEq\/L to K\u2009\u22645.5 mEq\/L) after the acute episode was significant, and inversely associated with the risk of mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Potassium levels prior to a severe hyperkalaemic event do not predict mortality. Conversely, following an episode of acute severe hyperkalaemia, serial kinetics of potassium trajectories predict the risk of death. Further evidence is needed to confirm these findings and clarify the optimal long-term management of these patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfab003","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T12:03:55Z","timestamp":1610625835000},"page":"522-530","source":"Crossref","is-referenced-by-count":14,"title":["Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1134-9051","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Gorriz","sequence":"first","affiliation":[{"name":"Department of Nephrology, Cl\u00ednico University Hospital, INCLIVA, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"D\u2019Marco","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Cl\u00ednico University Hospital, INCLIVA, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pastor-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Cl\u00ednico University Hospital, INCLIVA, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-6214","authenticated-orcid":false,"given":"Pablo","family":"Molina","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Universitario Dr Peset, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gonzalez-Rico","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Cl\u00ednico University Hospital, INCLIVA, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Puchades","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Cl\u00ednico University Hospital, INCLIVA, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Sanchis","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Cl\u00ednico University Hospital, INCLIVA, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Escudero","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Universitario Dr Peset, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Esta\u00f1","sequence":"additional","affiliation":[{"name":"Clinical Analysis Service, Dr Peset University Hospital, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"de la Espriella","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cl\u00ednico University Hospital, INCLIVA, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Nu\u00f1ez","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cl\u00ednico University Hospital, INCLIVA, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Pallard\u00f3","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Universitario Dr Peset, Universitat de Val\u00e8ncia, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cl\u00ednico University Hospital, INCLIVA, Universitat de Val\u00e8ncia, Valencia, Spain"},{"name":"Centro de Investigaci\u00f3n en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"2022022512001125900_gfab003-B1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archinte.158.8.917","article-title":"Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines","volume":"158","author":"Acker","year":"1998","journal-title":"Arch Intern Med"},{"key":"2022022512001125900_gfab003-B2","first-page":"685","article-title":"Disorders of potassium homeostasis: pathophysiology and management","volume":"56","author":"Hoskote","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"2022022512001125900_gfab003-B3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jacc.2003.06.021","article-title":"What is the optimal serum potassium level in cardiovascular patients?","volume":"43","author":"Macdonald","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2022022512001125900_gfab003-B4","first-page":"352","article-title":"The economic implications of hyperkalemia in a medicaid managed care population","volume":"12","author":"Desai","year":"2019","journal-title":"Am Health Drug Benefits"},{"key":"2022022512001125900_gfab003-B5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/ejhf.1757","article-title":"Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry","volume":"22","author":"Cooper","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022022512001125900_gfab003-B6","first-page":"CD012466","article-title":"Pharmacological interventions for heart failure in people with chronic kidney disease","volume":"2","author":"Lunney","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2022022512001125900_gfab003-B7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/jamainternmed.2020.0193","article-title":"Association between renin-angiotensin system blockade discontinuation and all-cause mortality among persons with low estimated glomerular filtration rate","volume":"180","author":"Qiao","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2022022512001125900_gfab003-B8","first-page":"202","article-title":"The clinical and economic burden of hyperkalemia on medicare and commercial payers","volume":"10","author":"Fitch","year":"2017","journal-title":"Am Health Drug Benefits"},{"key":"2022022512001125900_gfab003-B9","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.ekir.2020.06.004","article-title":"Post-discharge healthcare costs and readmission in patients with hyperkalemia-related hospitalizations","volume":"5","author":"Betts","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2022022512001125900_gfab003-B10","first-page":"127","article-title":"Haemolysis as an interference factor in clinical chemistry","volume":"2","author":"Sonntag","year":"1986","journal-title":"J Clin Chem Clin Biochem"},{"key":"2022022512001125900_gfab003-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v038.i08","article-title":"Multi-state models for panel data: the msm package for R","volume":"38","author":"Jackson","year":"2011","journal-title":"J Stat Soft"},{"key":"2022022512001125900_gfab003-B12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.117.030576","article-title":"Long-term potassium monitoring and dynamics in heart failure and risk of mortality","volume":"137","author":"N\u00fa\u00f1ez","year":"2018","journal-title":"Circulation"},{"key":"2022022512001125900_gfab003-B13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000479802","article-title":"Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes","volume":"46","author":"Collins","year":"2017","journal-title":"Am J Nephrol"},{"key":"2022022512001125900_gfab003-B14","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1186\/cc11872","article-title":"Severe hyperkalemia requiring hospitalization: predictors of mortality","volume":"16","author":"An","year":"2012","journal-title":"Crit Care"},{"key":"2022022512001125900_gfab003-B15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15441\/ceem.16.194","article-title":"A retrospective study of emergency department potassium disturbances: severity, treatment, and outcomes","volume":"4","author":"Singer","year":"2017","journal-title":"Clin Exp Emerg Med"},{"key":"2022022512001125900_gfab003-B16","doi-asserted-by":"crossref","first-page":"A386","DOI":"10.1016\/j.jval.2015.09.844","article-title":"Trends in emergency room visits due to hyperkalemia in the United States","volume":"18","author":"Aggarwal","year":"2015","journal-title":"Value Health"},{"key":"2022022512001125900_gfab003-B17","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.ejim.2013.02.010","article-title":"Hyperkalemia in the emergency department: etiology, symptoms and outcome of a life threatening electrolyte disorder","volume":"24","author":"Pfortm\u00fcller","year":"2013","journal-title":"Eur J Int Med"},{"key":"2022022512001125900_gfab003-B18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.5811\/westjem.2017.6.33033","article-title":"Severe hyperkalemia: can the electrocardiogram risk stratify for short-term adverse events?","volume":"18","author":"Durfey","year":"2017","journal-title":"West J Emerg Med"},{"key":"2022022512001125900_gfab003-B19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MEJ.0000000000000691","article-title":"Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference","volume":"27","author":"Lindner","year":"2020","journal-title":"Eur J Emerg Med"},{"key":"2022022512001125900_gfab003-B20","article-title":"The unappreciated role of extrarenal and gut sensors in modulating renal potassium handling: implications for diagnosis of dyskalemias and interpreting clinical trials","volume":"1","author":"Epstein","year":"2016","journal-title":"Kidney Int Rep"},{"key":"2022022512001125900_gfab003-B21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1159\/000351178","article-title":"Association between dietary sodium and potassium intake with chronic kidney disease in US adults: a cross-sectional study","volume":"37","author":"Sharma","year":"2013","journal-title":"Am J Nephrol"},{"key":"2022022512001125900_gfab003-B22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ki.2014.214","article-title":"The relationship between estimated sodium and potassium excretion and subsequent renal outcomes","volume":"86","author":"Smyth","year":"2014","journal-title":"Kidney Int"},{"key":"2022022512001125900_gfab003-B23","doi-asserted-by":"crossref","first-page":"F170","DOI":"10.1152\/ajprenal.1991.260.2.F170","article-title":"Stimulation of renin release by hyperkalemia in the nonfiltering kidney","volume":"260","author":"Lin","year":"1991","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022022512001125900_gfab003-B24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/ki.2014.281","article-title":"Renal outcomes and dietary potassium: the overshadowed electrolyte?","volume":"86","author":"Jablonski","year":"2014","journal-title":"Kidney Int"},{"key":"2022022512001125900_gfab003-B25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.jhh.1001575","article-title":"Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials","volume":"17","author":"Geleijnse","year":"2003","journal-title":"J Hum Hypertens"},{"key":"2022022512001125900_gfab003-B26","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/nu11061263","article-title":"Vegetable-based diets for chronic kidney disease? It is time to reconsider","volume":"11","author":"Cases","year":"2019","journal-title":"Nutrients"},{"key":"2022022512001125900_gfab003-B27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1681\/ASN.2010010079","article-title":"Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective","volume":"21","author":"Sterns","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2022022512001125900_gfab003-B28","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ndt\/gfz150","article-title":"Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study","volume":"35","author":"Laureati","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2022022512001125900_gfab003-B29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med"},{"key":"2022022512001125900_gfab003-B30","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"2022022512001125900_gfab003-B31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"key":"2022022512001125900_gfab003-B32","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.402","article-title":"Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors","volume":"17","author":"Pitt","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2022022512001125900_gfab003-B33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"2022022512001125900_gfab003-B34","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(19)32135-X","article-title":"Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"394","author":"Agarwal","year":"2019","journal-title":"Lancet"},{"key":"2022022512001125900_gfab003-B35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"Sodium zirconium cyclosilicate among individuals with hyperkalemia","volume":"14","author":"Spinowitz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022022512001125900_gfab003-B36","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1681\/ASN.2019050450","article-title":"A phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia","volume":"30","author":"Fishbane","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"2022022512001125900_gfab003-B37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/acem.13954","article-title":"Emergency potassium normalization treatment including sodium zirconium cyclosilicate: a phase II, randomized, double-blind, placebo-controlled study (ENERGIZE)","volume":"27","author":"Peacock","year":"2020","journal-title":"Acad Emerg Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfab003\/41937007\/gfab003.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/3\/522\/42613736\/gfab003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/3\/522\/42613736\/gfab003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T12:12:38Z","timestamp":1645791158000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/37\/3\/522\/6122707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2,4]]},"published-print":{"date-parts":[[2022,2,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfab003","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2021,2,4]]}}}